PROVECTUS BIOPHARMACEUTICALS, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2018
Total Assets: $2.0M
Liabilities Breakdown FY2018
Total Liabilities: $19.4M
Asset Breakdown
Total Assets: $2.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $51.0K | 2.6% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $72.5K | 3.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $899.2K | 45.2% |
| Other Assets | $965.5K | 48.6% |
Liabilities Breakdown
Total Liabilities: $19.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.3M | 17.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $16.1M | 82.9% |